Report on 2012 ISN Nexus Symposium: 'Bone and the Kidney'

Drüeke, Tilman B; Olgaard, Klaus
April 2013
Kidney International;Apr2013, Vol. 83 Issue 4, p557
Academic Journal
The Copenhagen 2012 Nexus symposium on 'Bone and the Kidney' followed the 'bench to bedside' approach of the Nexus symposia organized by the International Society of Nephrology. The main goal of the present symposium was to provide a unique forum for scientists and clinicians with an interest in the fascinating world of the many hormones and factors involved in mineral homeostasis, bone disease, and vascular calcification of patients with chronic kidney disease-mineral and bone disorder (CKD-MBD). The possibility of exchanging cutting-edge insights and discussing clinically relevant information on all aspects of the bone-kidney axis was open to all participants. The numerous lectures given at the symposium addressed current knowledge and recent advances in kidney and bone physiology, as well as the pathogenesis, diagnosis, and therapy of CKD-MBD, inspired by the intention to enhance the translation of basic science into clinical medicine. The lectures were followed by lively discussions of open questions and controversial issues. Our brief summary of interesting novel findings presented at this symposium is necessarily the result of a somewhat arbitrary choice among a wealth of exciting data brought to the attention of an enthusiastic audience.


Related Articles

  • Hyperphosphatemia in end-stage renal disease patients; Pathophysiological consequences. Llach, Francisco // Kidney International Supplement;Dec1999, Issue 73, pS-31 

    Examines the pathophysiological consequences of hyperphosphatemia in end-stage renal disease patients. Effect of elevated calcium and phosphorous products on risk of mortality; Factors affecting the development of secondary hyperparathyroidism, soft tissue calcification and calciphylaxis;...

  • Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. McCabe, Kristin M; Booth, Sarah L; Fu, Xueyan; Shobeiri, Navid; Pang, Judith J; Adams, Michael A; Holden, Rachel M // Kidney International;May2013, Vol. 83 Issue 5, p835 

    The leading cause of death in patients with chronic kidney disease (CKD) is cardiovascular disease, with vascular calcification being a key modifier of disease progression. A local regulator of vascular calcification is vitamin K. This γ-glutamyl carboxylase substrate is an essential cofactor...

  • Digital manifestations of tertiary hyperparathyroidism. Thomas, Leslie F; McCarthy, James T; Wenger, Doris E; Norby, Suzanne M // Kidney International;Sep2012, Vol. 82 Issue 6, p724 

    The article discusses a case of a 49-year-old man with end-stage renal disease on hemodialysis and tertiary hyperparathyroidism. It says that the man has a history of non-adherence to restriction of dietary phosphorus and also presents hypercalcemia; thus, hinders active vitamin D therapy. It...

  • Severe hyperkalemia following colon diversion surgery in a patient undergoing chronic hemodialysis: a case report. Kononowa, Nina; Dickenmann, Michael J.; Min Jeong Kim // Journal of Medical Case Reports;2013, Vol. 7 Issue 1, p1 

    Introduction: Potassium (K+) homeostasis in healthy subjects is maintained mainly by urinary excretion of K+. In patients with end-stage renal disease, the intestinal tract might assume an accessory K+ excretory role in the face of declining renal excretory function. Here, we report the case of...

  • Prevalence and functional effect of arteriovenous fistula calcifications, evaluated by spiral CT in chronic haemodialysis patients. Roca-Tey, R.; Páez, R.; Rivas, A.; Samon, R.; Ibrik, O.; Giménez, I.; Viladoms, J. // Nefrologia;Jun2009, Vol. 29 Issue 3, p214 

    Introduction: Vascular calcification is a common finding in patients (pts) with end-stage renal disease (ESRD). Objective: The aim of this cross-sectional study was to investigate the prevalence and functional effect of native arteriovenous fistula AVF (feeding artery and/or arterialized vein)...

  • Effect of Calcium and the Calcimimetic AMG 641 on Matrix-Gla Protein in Vascular Smooth Muscle Cells. Mendoza, Francisco; Martinez-Moreno, Julio; Almaden, Yolanda; Rodriguez-Ortiz, Maria; Lopez, Ignacio; Estepa, Jose; Henley, Charles; Rodriguez, Mariano; Aguilera-Tejero, Escolastico // Calcified Tissue International;Mar2011, Vol. 88 Issue 3, p169 

    Vascular calcification (VC) is frequently observed in patients with chronic renal failure and appears to be an active process involving transdifferentiation of vascular smooth muscle cells (VSMCs) to osteoblast-like cells. Reports of VC prevention in uremic rodents by calcimimetics coupled with...

  • Vitamin D and secreted Klotho: a long-awaited panacea for vascular calcification? Komaba, Hirotaka; Fukagawa, Masafumi // Kidney International;Dec2012, Vol. 82 Issue 12, p1248 

    Chronic kidney disease (CKD) is characterized by accelerated vascular calcification, which may in part be caused by deficiency of the anti-aging factor Klotho. Lau et al. demonstrate that administration of active vitamin D and its analog decreases aortic calcification in association with...

  • Renal function, calcium regulation, and time to hospitalization of patients with chronic kidney disease. Golzy, Mojgan; Bessette, Russell W.; Carter, Randy L. // BMC Nephrology;2013, Vol. 14 Issue 1, p1 

    Background: Chronic kidney disease is associated with disruption of the endocrine system that distorts the balance between calcitriol, calcium, phosphate and parathyroid hormone in the calcium regulation system. This can lead to calcification of the arterial tree and increased risk of...

  • Computational systems pharmacology and docking explored diosgenin targets causal and effectors pathogenic signalling network of vascular calcification. Manivannan, Jeganathan; Kumar, T. R. Barath; Arunagiri, Pandiyan; Balamurugan, Elumalai // Journal of Chemical & Pharmaceutical Research;2013, Vol. 5 Issue 1, p161 

    The Objective of this study is to investigate the multi-target potential of diosgenin on pathogenic network of vascular calcification due to the osteogenic transdifferentiation of vascular smooth muscle cell (VSMC). Target analysis of diosgenin was done via a 'reverse pharmacophore mapping' by...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics